The abstract is read at the publisher; the summary is JClub's.
In microsatellite stable colorectal cancer, tumor-intrinsic PTPN12 suppresses double-stranded RNA sensing and interferon signaling, enabling immune-refractory tumors.
- Why it matters: Endogenous dsRNA sensing and interferon responses are key for immune checkpoint inhibition, yet microsatellite stable colorectal cancers often lack this pathway with unclear intrinsic regulators.
- What they did: Using an in vivo CRISPR screen, the study identifies PTPN12 and shows TRIM28 is a direct substrate; PTPN12 dephosphorylates Y370 to stabilize repressive complexes and also rewires the cytoskeleton to disrupt dsRNA spatial organization.
- The result: Pharmacologically inducible PTPN12 knockdown inhibits pre-established tumor growth and overcomes immunotherapy resistance in vivo, matching PTPN12 ablation–linked dsRNA accumulation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.